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TENISAbstract Micropapillary carcinoma of thyroid is said to be low risk differentiated thyroid malig-
nancy with excellent prognosis. We report the identiﬁcation of an isolated FDG avid muscle deposit
in a treated case of micropapillary carcinoma of the right lobe and widely invasive follicular carci-
noma of the left lobe thyroid gland. Patient was found to have an elevated thyroglobulin level with
negative iodine scan (TENIS syndrome) on follow up at 6 months. An 18F FDG PET CT (18 ﬂuo-
rine-ﬂuorodeoxyglucose positron emission computed tomography) whole body study revealed a sol-
itary FDG avid deltoid muscle deposit which was histopathologically conﬁrmed to be metastatic
papillary carcinoma. While follicular carcinoma is known to have distant metastases, this may be
the ﬁrst reported case of solitary skeletal metastases from micropapillary carcinoma of thyroid
and probably the second reported skeletal muscle deposit from DTC detected on 18F FDG PET
CT done following elevated thyroglobulin level and negative 131 iodine WB scan (TENIS). This
case also assumes importance because it demonstrates possibility of metastases even from a micro-
papillary carcinoma in contrast to American Thyroid Association guidelines (2009) which suggests
that micropapillary carcinoma of thyroid does not merit further treatment after a Total Thyroidec-
tomy.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of National Cancer Institute,
Cairo University. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Metastases to muscles from differentiated thyroid carcinoma
(DTC) are very few. They metastasise commonly to the erector
spinae muscle [1] and are usually associated with other metas-
tases. To our knowledge solitary muscle metastases from DTC
have been reported in a right bicep muscle [2], trapezius muscle
Figure 1 Panel of microphotographs from Total Thyroidectomy specimen. (A) An encapsulated follicular patterned neoplasm with
capsular and vascular invasion (40· H&E). (B) Follicular epithelial cells arranged predominantly in microfollicular pattern (400· H&E).
(C) Focal areas of the neoplasm showing nuclear clearing and many intranuclear pseudoinclusions (400· H&E). (D) Another focus
showing a micropapillary carcinoma (40· H&E).
Figure 2 18F FDG PET CT whole body study showing a solitary focal uptake of 18F FDG (arrow marked) in the deltoid muscle (SUV
max 12.0) as seen in the PET image (B), CT and PET fusion image (C), MIP (maximal intensity projection) image (D) with no CT
detectable lesion in cross sectional CT image (A).
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Figure 3 USG of the left upper arm showed an echogenic nodule measuring 12 · 8 mm showing in the deltoid muscle anteriorly (arrow
marked). During excision lesion was localised with USG intraoperatively in left deltoid and a 2 · 2 cm swelling was identiﬁed and exposed
deep to the anterior ﬁbres of the left deltoid muscle.
Figure 4 Panel of microphotographs from metastatic deposit in the deltoid muscle. (A) A neoplasm showing follicular and papillary
patterns amidst skeletal muscle ﬁbres (100·H&E). (B) High power view showing nuclear clearing and many intranuclear pseudoinclusions
(400· H&E). (C) Neoplasm showing diffuse positivity for cytokeratin 19 (400·) on immunohistochemistry. (D) Neoplasm showing diffuse
nuclear positivity for TTF-1; inset showing positivity for thyroglobulin (400·) on immunohistochemistry.
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and none from micropapillary variant of DTC.
Case report
This 66 year old Indian male presented with long standing
swelling in the lower neck with ultrasonographic (USG) fea-
tures suggesting multinodular goitre. Fine needle aspiration
cytology (FNAC) showed a cellular follicular lesion with
oxyphilic changes. He underwent Total Thyroidectomy andhistopathologically was reported to have completely intrathy-
roidal widely invasive follicular carcinoma (3.3 · 2.5 · 2 cm)
in the left upper lobe with micropapillary carcinoma
(1 · 1 mm) in the right lobe (Fig. 1). Post operative diagnostic
131 iodine whole body scan was performed 3 weeks post sur-
gery which showed moderate residual thyroid tissue. Patient
was orally administered 2590 MBq of 131 iodine. Post therapy
WBI scan conﬁrmed the presence of only the residual thyroid
tissue and no cervical or distant metastasis. Subsequently on
6 month follow up, whole body 131-iodine scan was negative
50 M. Sarma et al.while thyroglobulin (off thyroxine) was 123.2 ng/ml. Patient
underwent ultrasound (USG) examination of neck and chest
X-ray which were non contributory. Whole body FDG PET
CT (non contrast) was advised. No FDG avid recurrence in
thyroid bed or lymph nodal metastases was noted. An isolated
FDG avid focal lesion was seen in the left deltoid muscle with
no corresponding CT lesion (Fig. 2). The Maximum Standard-
ised Uptake Value (SUV Max) of the lesion was 12.0 ml/g.
Later an USG of the left upper arm was performed as part of
presurgical workup and it showed an echogenic nodule measur-
ing 12 · 8 mmwith increased vascularity in the left deltoid mus-
cle anteriorly (Fig. 3). Pre operatively a 2 · 2 cm lesion was
identiﬁed and exposed deep to the anterior ﬁbres of the left del-
toid muscle. Excision biopsy and immunohistochemistry (IHC)
were reported as metastatic papillary carcinoma of thyroid.
Tumour cells are positive for thyroid transcription factor
(TTF)-1, thyroglobulin and cytokeratin (CK)-19 (Fig. 4).
Discussion
Distant thyroid metastases are seen in up to 10% of DTC
patients. Although rare, distant metastases have been reported
to involve the brain, breast, liver, kidney and skin. Metastasis
to the skeletal muscle is extremely rare in DTC even in cases of
follicular thyroid carcinoma in which haematogenous spread is
known [5]. Most common sites of metastases are to the lungs,
followed by the bone [6]. A probable hypothesis put forth is
that skeletal muscle is a hostile environment for the retention
and proliferation of cancer cells, including muscle motion,
unadapted muscle pH, and the muscle’s ability to remove
tumour-produced lactic acid [7].
The highlight of our case is that the distant metastases
proved to arise from the micropapillary component of DTC
rather than the follicular carcinoma counterpart. The lesion
was FDG avid; thus indicating an aggressive malignant poten-
tial. One must bear in mind the fact that in spite of guidelines
and recommendations suggesting no residual remnant ablation
with 131 iodine in micropapillary carcinoma DTC manage-
ment, cases need to be handled on an individual basis.
131I WBS negative thyroid cancer occurs in up to 20% of
patients with DTC and 18F FDG PET CT has become a useful
modality for detecting and localising recurrences [8]. 18F
FDG-PET positivity also implies more aggressive tumour biol-
ogy and poorer prognosis in primary thyroid carcinoma [9].
FDG-PET positivity has also been reported to strongly corre-
late with extrathyroidal extension and central lymph nodemetastases in primary PTMC [10] indicating FDG-PET posi-
tivity in micropapillary carcinoma of thyroid to be a potential
risk factor for preoperative risk stratiﬁcation. Potential clinical
application could be patient selection for more extensive thy-
roid resection or prophylactic central neck dissection at the
time of Total Thyroidectomy.Conﬂict of interest
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